|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000102755 |
Summary for FLT1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000102755 | Gene symbol | FLT1 |
| Gene name | fms related receptor tyrosine kinase 1 | |
| HGNC | 3763 | |
| Entrez ID | 2321 | |
| Gene type | protein_coding | |
| Synonyms | FLT1|VEGFR1 | |
| UniProtAcc | P17948 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000102755 | FLT1 | DB00398 | Sorafenib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB01268 | Sunitinib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB04879 | Vatalanib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB05075 | TG-100801 | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB05913 | OSI-930 | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB05932 | Denibulin | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB06080 | Linifanib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB06101 | IMC-1C11 | BiotechDrug |
| ENSG00000102755 | FLT1 | DB06589 | Pazopanib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB06626 | Axitinib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB07288 | N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB08896 | Regorafenib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB09078 | Lenvatinib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB09079 | Nintedanib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB09221 | Polaprezinc | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB10770 | Foreskin fibroblast (neonatal) | BiotechDrug |
| ENSG00000102755 | FLT1 | DB11800 | Tivozanib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB12010 | Fostamatinib | SmallMoleculeDrug |
| ENSG00000102755 | FLT1 | DB15685 | Selpercatinib | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
| ENSG00000102755 | FLT1 | DB00398 | Sorafenib | SmallMoleculeDrug | Renal Cell Cancer (RCC),Liver Cancer,Thyroid Cancer |
| ENSG00000102755 | FLT1 | DB01268 | Sunitinib | SmallMoleculeDrug | Gastrointestinal Stromal Tumors, Renal Cell Cancer (RCC),Pancreatic Cancer |
| ENSG00000102755 | FLT1 | DB06589 | Pazopanib | SmallMoleculeDrug | Renal Cell Cancer (RCC),Soft Tissue Sarcoma |
| ENSG00000102755 | FLT1 | DB06626 | Axitinib | SmallMoleculeDrug | Renal Cell Cancer (RCC) |
| ENSG00000102755 | FLT1 | DB08896 | Regorafenib | SmallMoleculeDrug | Colon Cancer,Rectal Cancer,Gastrointestinal Stromal Tumors,Liver Cancer |
| ENSG00000102755 | FLT1 | DB09078 | Lenvatinib | SmallMoleculeDrug | Endometrial Cancer, Renal Cell Cancer (RCC),Liver Cancer,Thyroid Cancer |
| ENSG00000102755 | FLT1 | DB11800 | Tivozanib | SmallMoleculeDrug | Renal Cell Cancer (RCC) |
| ENSG00000102755 | FLT1 | DB15685 | Selpercatinib | SmallMoleculeDrug | Non-Small Cell Lung Cancer,Thyroid Cancer |
Top |
Structure and expression level for FLT1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| FLT1 | 1.61e+03 | 1.18e+00 | 2.44e-01 | 4.86e+00 | 1.17e-06 | 1.26e-05 | HNSC |
Top |
Sex-biased somatic mutation for FLT1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for FLT1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg01899253 | chr13:28495919 | CGI:chr13:28493651-28495840 | promoter | 4.04e-01 | 5.26e-01 | -2.00e+00 | 4.57e-02 | 4.83e-02 | -1.23e-01 |
| READ | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 1.86e-01 | 3.17e-01 | -3.03e+00 | 2.46e-03 | 8.73e-03 | -1.31e-01 |
| READ | cg01899253 | chr13:28495919 | CGI:chr13:28493651-28495840 | promoter | 1.02e-01 | 2.10e-01 | -2.89e+00 | 3.82e-03 | 1.25e-02 | -1.08e-01 |
| GBM | cg22574825 | chr13:28494850 | CGI:chr13:28493651-28495840 | UTR,promoter,exon,gene body | 1.29e-01 | 2.59e-01 | -2.19e+00 | 2.82e-02 | 4.09e-02 | -1.29e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg22574825 | chr13:28494850 | CGI:chr13:28493651-28495840 | UTR,promoter,exon,gene body | 1.33e-01 | 2.94e-02 | 3.11e+00 | 1.85e-03 | 2.67e-03 | 1.03e-01 |
| KIRC | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 2.60e-01 | 1.39e-01 | 4.24e+00 | 2.24e-05 | 5.50e-05 | 1.21e-01 |
| LUAD | cg03662064 | chr13:28495751 | CGI:chr13:28493651-28495840 | promoter | 2.51e-01 | 1.48e-01 | 3.09e+00 | 2.03e-03 | 3.51e-03 | 1.03e-01 |
| HNSC | cg22574825 | chr13:28494850 | CGI:chr13:28493651-28495840 | UTR,promoter,exon,gene body | 2.31e-01 | 5.15e-02 | 3.15e+00 | 1.64e-03 | 2.77e-03 | 1.80e-01 |
| LUSC | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 3.08e-01 | 1.62e-01 | 2.82e+00 | 4.85e-03 | 7.97e-03 | 1.47e-01 |
| LUSC | cg01899253 | chr13:28495919 | CGI:chr13:28493651-28495840 | promoter | 2.50e-01 | 1.22e-01 | 2.74e+00 | 6.21e-03 | 9.61e-03 | 1.28e-01 |
| COAD | cg10501128 | chr13:28494963 | CGI:chr13:28493651-28495840 | UTR,promoter,exon,gene body | 1.53e-01 | 4.51e-02 | 2.23e+00 | 2.56e-02 | 3.00e-02 | 1.07e-01 |
| COAD | cg03247926 | chr13:28495486 | CGI:chr13:28493651-28495840 | promoter | 1.99e-01 | 6.05e-02 | 2.72e+00 | 6.62e-03 | 1.03e-02 | 1.39e-01 |
| BLCA | cg06272611 | chr13:28494430 | CGI:chr13:28493651-28495840 | promoter,gene body | 2.99e-01 | 1.28e-01 | 2.78e+00 | 5.36e-03 | 8.60e-03 | 1.70e-01 |
| KIRP | cg01899253 | chr13:28495919 | CGI:chr13:28493651-28495840 | promoter | 3.19e-01 | 1.67e-01 | 2.91e+00 | 3.61e-03 | 5.41e-03 | 1.52e-01 |
| CHOL | cg09887007 | chr13:28495366 | CGI:chr13:28493651-28495840 | promoter | 2.07e-01 | 2.42e-02 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 1.83e-01 |
| CHOL | cg03662064 | chr13:28495751 | CGI:chr13:28493651-28495840 | promoter | 3.75e-01 | 1.72e-01 | 2.58e+00 | 9.87e-03 | 2.15e-02 | 2.03e-01 |
| CHOL | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 3.58e-01 | 2.09e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 1.50e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03662064 | chr13:28495751 | CGI:chr13:28493651-28495840 | promoter | 2.94e-01 | 1.06e-01 | 1.06e+01 | 4.35e-26 | 4.11e-25 | 1.88e-01 |
| BRCA | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 4.21e-01 | 1.61e-01 | 1.05e+01 | 8.77e-26 | 8.03e-25 | 2.60e-01 |
| BRCA | cg01899253 | chr13:28495919 | CGI:chr13:28493651-28495840 | promoter | 4.04e-01 | 1.75e-01 | 8.06e+00 | 7.53e-16 | 2.93e-15 | 2.29e-01 |
| LUAD | cg14283783 | chr13:28495804 | CGI:chr13:28493651-28495840 | promoter | 3.18e-01 | 1.75e-01 | 3.22e+00 | 1.27e-03 | 3.75e-03 | 1.43e-01 |
| KIRP | cg03662064 | chr13:28495751 | CGI:chr13:28493651-28495840 | promoter | 2.63e-01 | 1.37e-01 | 2.52e+00 | 1.18e-02 | 1.88e-02 | 1.26e-01 |
Top |
Exon skipping events with PSI in TCGA for FLT1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for FLT1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for FLT1 |
TFs related to FLT1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BLCA | BARX2 | FLT1 | 3.26e+00 | 4.70e-03 | 4.29e+00 | 9.85e-01 | Female-biased |
| BLCA | MYNN | FLT1 | 2.96e+00 | 2.32e-03 | 4.17e+00 | 9.85e-01 | Female-biased |
| BLCA | SRY | FLT1 | 3.48e+00 | 8.99e-03 | 4.35e+00 | 9.81e-01 | Female-biased |
| BLCA | ZNF418 | FLT1 | 1.61e+00 | 2.26e-05 | 3.99e+00 | 9.83e-01 | Female-biased |
| BRCA | BARX2 | FLT1 | 3.38e+00 | 5.68e-03 | 4.77e+00 | 9.88e-01 | Female-biased |
| BRCA | HOXB8 | FLT1 | 3.25e+00 | 8.63e-03 | 4.50e+00 | 9.81e-01 | Female-biased |
| BRCA | SRY | FLT1 | 3.48e+00 | 7.07e-03 | 4.80e+00 | 9.87e-01 | Female-biased |
| BRCA | ZFP82 | FLT1 | 2.70e+00 | 3.50e-03 | 4.23e+00 | 9.80e-01 | Female-biased |
| BRCA | ZNF232 | FLT1 | 3.69e+00 | 1.40e-02 | 4.80e+00 | 9.80e-01 | Female-biased |
| BRCA | ZNF418 | FLT1 | 2.11e+00 | 9.93e-05 | 4.67e+00 | 9.93e-01 | Female-biased |
| DLBC | PRDM6 | FLT1 | 4.22e+00 | 9.86e-01 | 3.06e+00 | 3.05e-03 | Male-biased |
| DLBC | ZNF182 | FLT1 | 4.20e+00 | 9.84e-01 | 3.13e+00 | 4.35e-03 | Male-biased |
| DLBC | ZNF22 | FLT1 | 4.20e+00 | 9.85e-01 | 3.09e+00 | 3.65e-03 | Male-biased |
| DLBC | ZNF235 | FLT1 | 4.64e+00 | 9.94e-01 | 3.18e+00 | 1.05e-03 | Male-biased |
| DLBC | ZNF287 | FLT1 | 4.65e+00 | 9.93e-01 | 3.29e+00 | 1.50e-03 | Male-biased |
| DLBC | ZNF487 | FLT1 | 4.41e+00 | 9.89e-01 | 3.28e+00 | 3.45e-03 | Male-biased |
| LGG | ZNF418 | FLT1 | 4.18e+00 | 9.81e-01 | 3.59e+00 | 5.17e-03 | Male-biased |
FLT1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for FLT1 |
RBPs related to ES in FLT1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | KHDRBS1 | exon_skip_102634 | 1.02e+01 | 1.48e-03 | 1.09e+01 | 9.97e-01 | Female-biased |
| THCA | MATR3 | exon_skip_102633 | 7.07e+00 | 1.52e-03 | 7.52e+00 | 9.88e-01 | Female-biased |
| PAAD | KHDRBS1 | exon_skip_102634 | 1.04e+01 | 2.35e-03 | 1.08e+01 | 9.96e-01 | Female-biased |
FLT1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7993616 | chr13:23467976:G:A | - | 0.228086533770833 | 0.0468159761002552 | READ | Female-baised eQTL |
| rs10162031 | chr13:23468420:C:T | - | 0.228086533770833 | 0.0468159761002552 | READ | Female-baised eQTL |
| rs3764068 | chr13:23468759:G:A | - | 0.228086533770833 | 0.0468159761002552 | READ | Female-baised eQTL |
| rs73460239 | chr13:38328004:G:A | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs17057757 | chr13:38328023:C:T | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs73460244 | chr13:38328045:T:A | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs7334232 | chr13:38328316:A:G | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs1878948 | chr13:38328456:C:T | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs6563610 | chr13:38328811:A:C | - | 0.174448632433745 | 0.00313901998830865 | KIRP | Female-baised eQTL |
| rs73460205 | chr13:38321244:A:G | - | 0.182817250840327 | 0.00763971830129115 | KIRP | Female-baised eQTL |
| rs7317565 | chr13:38322053:A:G | - | 0.182817250840327 | 0.00763971830129115 | KIRP | Female-baised eQTL |
| rs17057716 | chr13:38322070:G:A | - | 0.182817250840327 | 0.00763971830129115 | KIRP | Female-baised eQTL |
| rs74047533 | chr13:38322191:T:A | - | 0.182817250840327 | 0.00763971830129115 | KIRP | Female-baised eQTL |
| rs73460223 | chr13:38324687:C:G | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs2104818 | chr13:38324893:T:C | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs2094893 | chr13:38325146:C:A | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs1330976 | chr13:38325499:T:C | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs61087779 | chr13:38326234:C:T | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs17057738 | chr13:38326271:C:A | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs55671132 | chr13:38326808:T:C | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs111368796 | chr13:38326956:C:T | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs61569024 | chr13:38327634:C:T | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs58014955 | chr13:38327674:G:T | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs73460238 | chr13:38327801:G:T | - | 0.180893009430893 | 0.00926024027901652 | KIRP | Female-baised eQTL |
| rs56306542 | chr13:38329285:A:G | - | 0.175363502041079 | 0.0107122374985009 | KIRP | Female-baised eQTL |
| rs17625898 | chr13:28358693:T:G | gene | 0.142233289377925 | 0.0364042838256259 | KIRP | Female-baised eQTL |
| rs66705061 | chr13:34268587:C:T | - | 0.139780448700124 | 0.0435246000207501 | KIRP | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17075455 | chr13:31117507:T:A | - | 0.15582448273998 | 0.0200265193852801 | PAAD | Male-baised eQTL |
| rs76813811 | chr13:31117039:T:G | - | 0.166240447446827 | 0.0409565384495893 | PAAD | Male-baised eQTL |
| rs678428 | chr13:36909889:G:A | - | -0.105257458391094 | 0.00689750046061585 | KIRP | Male-baised eQTL |
| rs9545850 | chr13:35941884:C:T | - | 0.101632104712856 | 0.00406499969247342 | LIHC | Male-baised eQTL |
| rs644631 | chr13:31524349:C:T | - | -0.0467273856396628 | 0.0253866551153026 | LIHC | Male-baised eQTL |
| rs17615729 | chr13:27911817:C:T | - | 0.0935281830749795 | 0.0297939262569765 | LIHC | Male-baised eQTL |
| rs7981042 | chr13:30556849:T:C | - | -0.074429920712048 | 0.00740179414392106 | LGG | Male-baised eQTL |
| rs7984483 | chr13:30556947:G:T | - | -0.074429920712048 | 0.00740179414392106 | LGG | Male-baised eQTL |
| rs9508798 | chr13:30557299:G:T | - | -0.0749448698821261 | 0.00760138702796974 | LGG | Male-baised eQTL |
| rs9508796 | chr13:30556108:G:A | - | -0.0745019225045235 | 0.00785025182789568 | LGG | Male-baised eQTL |
| rs9508797 | chr13:30556402:T:C | - | -0.0745019225045235 | 0.00785025182789568 | LGG | Male-baised eQTL |
| rs7984366 | chr13:30557048:C:T | - | -0.0726086157677972 | 0.0115017638911983 | LGG | Male-baised eQTL |
| rs8001518 | chr13:30556757:C:T | - | -0.0709282451811047 | 0.0139812494365866 | LGG | Male-baised eQTL |
| rs17074718 | chr13:30557478:T:C | - | 0.0683815108982226 | 0.023468444888478 | LGG | Male-baised eQTL |
| rs10514839 | chr13:35887031:T:C | - | 0.0714802199191504 | 0.0398438235735287 | LGG | Male-baised eQTL |
| rs73155723 | chr13:19100702:A:C | - | 0.109466469917526 | 4.05196461099703e-05 | BLCA | Male-baised eQTL |
| rs55885545 | chr13:19104830:T:C | - | 0.108321506908218 | 4.3726549602362e-05 | BLCA | Male-baised eQTL |
| rs73155715 | chr13:19089224:A:G | - | 0.09948440303162 | 7.15213826048223e-05 | BLCA | Male-baised eQTL |
| rs12430392 | chr13:19088027:G:A | - | 0.0969017210845444 | 0.000125529443801556 | BLCA | Male-baised eQTL |
| rs73155729 | chr13:19122637:G:A | - | 0.100000906958209 | 0.000149960266746875 | BLCA | Male-baised eQTL |
| rs138853471 | chr13:19201940:C:T | - | -0.069257738904582 | 0.000252003289775419 | BLCA | Male-baised eQTL |
| rs73155754 | chr13:19148352:G:C | - | 0.0928874372864038 | 0.000425404680275913 | BLCA | Male-baised eQTL |
| rs527937 | chr13:19219419:G:A | - | 0.0693328916321112 | 0.000549916941446981 | BLCA | Male-baised eQTL |
| rs144852330 | chr13:19199698:C:T | - | -0.0652603565364126 | 0.000691230717271849 | BLCA | Male-baised eQTL |
| rs28376808 | chr13:19205065:G:C | - | 0.0676989939232633 | 0.000695438548671665 | BLCA | Male-baised eQTL |
| rs3864944 | chr13:19200082:T:C | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs1033943 | chr13:19200089:G:A | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs7335047 | chr13:19201325:C:A | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs55798023 | chr13:19202033:C:T | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs9512024 | chr13:19202175:C:T | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs4770895 | chr13:19202377:T:C | - | -0.0650701623403646 | 0.000759452685947367 | BLCA | Male-baised eQTL |
| rs533309 | chr13:19219965:T:C | - | 0.0673728846918298 | 0.000817550376358622 | BLCA | Male-baised eQTL |
| rs667004 | chr13:19202379:T:A | - | 0.0650749528948929 | 0.000834541868868838 | BLCA | Male-baised eQTL |
| rs115152530 | chr13:19201615:A:G | - | -0.064660400616627 | 0.000944957079278062 | BLCA | Male-baised eQTL |
| rs4769450 | chr13:19202888:A:G | - | -0.0642084586066609 | 0.00100723169619199 | BLCA | Male-baised eQTL |
| rs4769446 | chr13:19202581:A:C | - | -0.0639354123498683 | 0.00107339691448685 | BLCA | Male-baised eQTL |
| rs28585405 | chr13:19204866:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs28646088 | chr13:19204912:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs612042 | chr13:19205642:A:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2611328 | chr13:19205865:C:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs610221 | chr13:19206062:T:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs609741 | chr13:19206215:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs609426 | chr13:19206230:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2774456 | chr13:19206442:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2774455 | chr13:19206443:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs542992 | chr13:19206475:G:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs543802 | chr13:19206555:T:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs573394 | chr13:19207512:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs574308 | chr13:19207605:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs575126 | chr13:19207669:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs577791 | chr13:19207968:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs671836 | chr13:19208052:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs671831 | chr13:19208055:A:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs369575779 | chr13:19208839:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs499636 | chr13:19209160:A:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs643158 | chr13:19209923:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs642279 | chr13:19210120:A:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs641048 | chr13:19210375:A:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs641017 | chr13:19210398:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs640130 | chr13:19210590:A:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2774452 | chr13:19210750:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs471571 | chr13:19211268:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs113220197 | chr13:19212711:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs192420758 | chr13:19213334:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs141668426 | chr13:19213399:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs373107595 | chr13:19213730:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs149556741 | chr13:19214527:T:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs144633848 | chr13:19215778:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs143189128 | chr13:19218559:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs140293661 | chr13:19218730:A:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs674975 | chr13:19218891:C:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs529779 | chr13:19219642:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs531537 | chr13:19219789:A:G | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs659766 | chr13:19220002:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs562595 | chr13:19220876:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2477803 | chr13:19221412:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2765206 | chr13:19221502:T:C | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs677644 | chr13:19225078:C:T | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs2611295 | chr13:19228089:G:A | - | 0.0656974823406755 | 0.00130194141884507 | BLCA | Male-baised eQTL |
| rs144389264 | chr13:19217066:C:G | - | 0.0655506408731687 | 0.0013794941800792 | BLCA | Male-baised eQTL |
| rs8002184 | chr13:19217367:T:C | - | 0.0655506408731687 | 0.0013794941800792 | BLCA | Male-baised eQTL |
| rs148308763 | chr13:19218222:C:T | - | 0.0655506408731687 | 0.0013794941800792 | BLCA | Male-baised eQTL |
| rs639683 | chr13:19204114:G:A | - | 0.0650501551041646 | 0.00150348076182384 | BLCA | Male-baised eQTL |
| rs2011436 | chr13:19230797:T:C | - | 0.0633437893303681 | 0.00153679527830368 | BLCA | Male-baised eQTL |
| rs2611296 | chr13:19228748:T:A | - | 0.0649605980096856 | 0.00156565617222176 | BLCA | Male-baised eQTL |
| rs477064 | chr13:19211873:A:G | - | 0.0649784290130949 | 0.00173189857251434 | BLCA | Male-baised eQTL |
| rs147163864 | chr13:19228914:C:T | - | 0.0640031856399001 | 0.00203390706907465 | BLCA | Male-baised eQTL |
| rs4769448 | chr13:19202747:T:C | - | -0.0610598155171307 | 0.00216195655274609 | BLCA | Male-baised eQTL |
| rs4769449 | chr13:19202781:A:C | - | -0.0610598155171307 | 0.00216195655274609 | BLCA | Male-baised eQTL |
| rs112586024 | chr13:19229464:T:G | - | 0.0635210672303123 | 0.00222571401489096 | BLCA | Male-baised eQTL |
| rs373421490 | chr13:19223241:A:T | - | 0.0642645125675321 | 0.00231402340289726 | BLCA | Male-baised eQTL |
| rs360219 | chr13:19232566:C:T | - | 0.0613112588479953 | 0.00334466354187147 | BLCA | Male-baised eQTL |
| rs360221 | chr13:19234146:T:C | - | 0.0613112588479953 | 0.00334466354187147 | BLCA | Male-baised eQTL |
| rs605495 | chr13:19231010:C:T | - | 0.0623569424044848 | 0.00364201557934587 | BLCA | Male-baised eQTL |
| rs375202608 | chr13:19107491:G:A | - | 0.0741893821271564 | 0.00402902970120557 | BLCA | Male-baised eQTL |
| rs577283 | chr13:19229825:C:T | - | 0.0723044271490649 | 0.00442949846563652 | BLCA | Male-baised eQTL |
| rs9511880 | chr13:19170956:T:G | - | 0.0710199433173534 | 0.0045616014714555 | BLCA | Male-baised eQTL |
| rs9512156 | chr13:19222805:C:T | - | -0.0570467624871955 | 0.00501041233041579 | BLCA | Male-baised eQTL |
| rs4769447 | chr13:19202714:T:C | - | -0.0553466128007892 | 0.00633577544686636 | BLCA | Male-baised eQTL |
| rs9599755 | chr13:34861415:T:C | - | 0.096370358164905 | 0.016317723717447 | BLCA | Male-baised eQTL |
| rs9551557 | chr13:28890333:C:A | - | 0.0744890207334385 | 0.0211761152479804 | BLCA | Male-baised eQTL |
| rs7490450 | chr13:29241470:A:G | - | 0.0486501617806192 | 0.025078412863806 | BLCA | Male-baised eQTL |
| rs9599753 | chr13:34860935:G:A | - | 0.0874424807041545 | 0.0347402410174046 | BLCA | Male-baised eQTL |
| rs9599754 | chr13:34861060:C:T | - | 0.0874424807041545 | 0.0347402410174046 | BLCA | Male-baised eQTL |
| rs12865401 | chr13:29176806:C:T | - | 0.051788001415574 | 0.0362312690924677 | BLCA | Male-baised eQTL |
| rs11617847 | chr13:29206966:G:C | - | 0.0516879604347486 | 0.0380951075218573 | BLCA | Male-baised eQTL |
| rs11617962 | chr13:29172357:C:A | - | 0.0507608311272671 | 0.0409834418858035 | BLCA | Male-baised eQTL |
| rs7328324 | chr13:29178056:C:T | - | 0.0506876976633042 | 0.0429226766864216 | BLCA | Male-baised eQTL |
| rs34032667 | chr13:29171143:T:A | - | 0.0497391636424156 | 0.0438646124782061 | BLCA | Male-baised eQTL |
| rs12877143 | chr13:29173177:T:G | - | 0.0503080812183789 | 0.0452734827867227 | BLCA | Male-baised eQTL |
| rs9574543 | chr13:35770389:C:G | - | 0.0463652563772096 | 0.0461110739549516 | BLCA | Male-baised eQTL |
| rs9553800 | chr13:19239767:G:T | - | 0.0400773468111109 | 0.0465745581946815 | BLCA | Male-baised eQTL |
| rs200266146 | chr13:19274013:G:A | - | 0.0395789755878557 | 0.047824859273196 | BLCA | Male-baised eQTL |
| rs11617704 | chr13:29171817:G:C | - | 0.049866492790175 | 0.048067537094457 | BLCA | Male-baised eQTL |
| rs12868391 | chr13:29175005:G:A | - | 0.049866492790175 | 0.048067537094457 | BLCA | Male-baised eQTL |
| rs12858732 | chr13:29179465:C:A | - | 0.0499722659872203 | 0.0483159121747725 | BLCA | Male-baised eQTL |
| rs12866752 | chr13:29180157:C:T | - | 0.0499722659872203 | 0.0483159121747725 | BLCA | Male-baised eQTL |
| rs11147367 | chr13:29181165:G:T | - | 0.0499722659872203 | 0.0483159121747725 | BLCA | Male-baised eQTL |
| rs7333294 | chr13:22103220:T:C | - | -0.18234022851065 | 4.64323923443514e-07 | COAD | Male-baised eQTL |
| rs12871501 | chr13:22073981:T:A | - | 0.173142058848566 | 8.00095800847942e-07 | COAD | Male-baised eQTL |
| rs6490696 | chr13:22100082:T:C | - | -0.126230602853688 | 0.000268148548321623 | COAD | Male-baised eQTL |
| rs9532065 | chr13:37479779:A:G | - | 0.167929517409392 | 0.00158194416458925 | COAD | Male-baised eQTL |
| rs78444710 | chr13:37449791:C:T | - | 0.157110258434541 | 0.00244459385508409 | COAD | Male-baised eQTL |
| rs9547881 | chr13:37450825:G:A | - | 0.157110258434541 | 0.00244459385508409 | COAD | Male-baised eQTL |
| rs74526232 | chr13:22104777:T:G | - | 0.135241044481461 | 0.00358129942434426 | COAD | Male-baised eQTL |
| rs9547879 | chr13:37445442:A:T | - | 0.150610404726185 | 0.00393059443899704 | COAD | Male-baised eQTL |
| rs9547878 | chr13:37443604:C:A | - | 0.152323890195914 | 0.00404728706280858 | COAD | Male-baised eQTL |
| rs12428847 | chr13:33319170:A:T | - | 0.0996935451891686 | 0.00551021412073727 | COAD | Male-baised eQTL |
| rs7317019 | chr13:37483675:C:T | - | 0.138389240453432 | 0.0111242043123472 | COAD | Male-baised eQTL |
| rs9512533 | chr13:27067556:T:C | - | -0.0686232735475837 | 0.0148743323887473 | COAD | Male-baised eQTL |
| rs9547885 | chr13:37457261:T:C | - | 0.129192431188168 | 0.0151687315992837 | COAD | Male-baised eQTL |
| rs76935019 | chr13:37457333:T:G | - | 0.129192431188168 | 0.0151687315992837 | COAD | Male-baised eQTL |
| rs12429268 | chr13:37457805:T:C | - | 0.129192431188168 | 0.0151687315992837 | COAD | Male-baised eQTL |
| rs11842801 | chr13:31436405:G:C | - | 0.0797256554988773 | 0.0235386743886848 | COAD | Male-baised eQTL |
| rs11842809 | chr13:31436464:G:A | - | 0.0797256554988773 | 0.0235386743886848 | COAD | Male-baised eQTL |
| rs872271 | chr13:23100547:C:T | - | 0.0644221309630309 | 0.0240078354947543 | COAD | Male-baised eQTL |
| rs2810696 | chr13:23988811:G:C | - | -0.0630945284825898 | 0.0246464646987879 | COAD | Male-baised eQTL |
| rs3809335 | chr13:25287439:A:G | - | 0.116513450449283 | 0.0248386697702937 | COAD | Male-baised eQTL |
| rs9315551 | chr13:38099504:C:G | - | 0.0787790387527912 | 0.0255392010927606 | COAD | Male-baised eQTL |
| rs2298072 | chr13:25165375:C:T | - | 0.145953829015806 | 0.0260694860866345 | COAD | Male-baised eQTL |
| rs55990439 | chr13:31436530:G:T | - | 0.0787446531705192 | 0.0264838531155543 | COAD | Male-baised eQTL |
| rs73467837 | chr13:33160167:T:C | - | 0.0940937127390504 | 0.0299731396738871 | COAD | Male-baised eQTL |
| rs1924190 | chr13:38118683:G:T | - | 0.0744256051235505 | 0.0312173114156724 | COAD | Male-baised eQTL |
| rs1886801 | chr13:23985760:A:T | - | -0.0587570871521556 | 0.0344816170646923 | COAD | Male-baised eQTL |
| rs1924303 | chr13:37673369:C:T | - | 0.0841214878283738 | 0.0348155055484748 | COAD | Male-baised eQTL |
| rs1327984 | chr13:31654588:C:T | - | 0.0631738076645322 | 0.0359948023932208 | COAD | Male-baised eQTL |
| rs2492086 | chr13:23987702:T:C | - | -0.0602565804733207 | 0.0361322029883509 | COAD | Male-baised eQTL |
| rs4771157 | chr13:27712611:C:T | - | 0.0584300967236558 | 0.0363561006381686 | COAD | Male-baised eQTL |
| rs9554144 | chr13:27714175:A:G | - | 0.0586743059713122 | 0.037814584569367 | COAD | Male-baised eQTL |
| rs34746121 | chr13:35564160:G:T | - | 0.0704007628306132 | 0.0385765918658332 | COAD | Male-baised eQTL |
| rs35981284 | chr13:35564953:A:G | - | 0.0704007628306132 | 0.0385765918658332 | COAD | Male-baised eQTL |
| rs35474819 | chr13:35565094:G:A | - | 0.0704007628306132 | 0.0385765918658332 | COAD | Male-baised eQTL |
| rs9547934 | chr13:37544242:T:C | - | 0.104106925770984 | 0.0390190611223748 | COAD | Male-baised eQTL |
| rs17604551 | chr13:29608227:A:G | - | 0.0916653218807305 | 0.0436947306084742 | COAD | Male-baised eQTL |
| rs4769194 | chr13:22099731:A:G | - | -0.0737172115090358 | 0.0450773620064689 | COAD | Male-baised eQTL |
| rs9548017 | chr13:37687769:C:T | - | 0.0823669811000414 | 0.0455923510598592 | COAD | Male-baised eQTL |
| rs9548011 | chr13:37671979:G:C | - | 0.0821165983655362 | 0.0467675713216542 | COAD | Male-baised eQTL |
| rs9576461 | chr13:38127473:G:T | - | 0.0769711341911594 | 0.0481330345397977 | COAD | Male-baised eQTL |
| rs6490697 | chr13:22104872:T:G | - | -0.072292194774621 | 0.0488594920049397 | COAD | Male-baised eQTL |
| rs10492459 | chr13:29883157:G:A | - | 0.111267270720599 | 0.0491409542298436 | COAD | Male-baised eQTL |
| rs2296389 | chr13:33167940:C:G | - | 0.0866233114608448 | 0.0495417368484857 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg08508761 | chr13:28356410 | gene | -0.374809939571951 | 6.57853805120591e-06 | -0.5238706412209514 | 3.1026154731334036e-08 | PAAD |
| cg27423357 | chr13:28389569 | gene,exon,UTR | -0.373974050913987 | 7.04774386048145e-06 | -0.5422956200645263 | 8.29042445915778e-08 | PAAD |
| cg02186409 | chr13:28357410 | gene | -0.287528390098096 | 9.30744523543982e-13 | -0.5095385886964905 | 1.1194729889896433e-14 | KIRP |
| cg06021990 | chr13:28338609 | gene | -0.191059159562149 | 8.37887897773533e-08 | -0.41201666515353663 | 1.2244425543204056e-09 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of FLT1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000102755 | FLT1 | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
| ENSG00000102755 | FLT1 | C0007114 | Malignant neoplasm of skin | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0013366 | Dyschondroplasias | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0018923 | Hemangiosarcoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0025202 | melanoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0025237 | Melnick-Needles Syndrome | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0026760 | Multiple Epiphyseal Dysplasia | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0029422 | Osteochondrodysplasias | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0032914 | Pre-Eclampsia | 2 | CTD_human |
| ENSG00000102755 | FLT1 | C0036391 | Schwartz-Jampel Syndrome | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0037286 | Skin Neoplasms | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0038015 | Spondyloepiphyseal Dysplasia | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0041948 | Uremia | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0235874 | Disease Exacerbation | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0239946 | Fibrosis, Liver | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0432272 | Van Buchem disease | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C0678222 | Breast Carcinoma | 2 | CTD_human |
| ENSG00000102755 | FLT1 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
| ENSG00000102755 | FLT1 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
| ENSG00000102755 | FLT1 | C2937358 | Cerebral Hemorrhage | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C3541456 | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C4551479 | Schwartz-Jampel Syndrome, Type 1 | 1 | CTD_human |
| ENSG00000102755 | FLT1 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |